You have 9 free searches left this month | for more free features.

Schizophrenia ; Cannabis

Showing 1 - 25 of 3,238

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Schizophrenia, Cannabis Use Disorder Trial in Neuilly sur Marne, Neuilly-sur-Marne (tDCS)

Recruiting
  • Schizophrenia
  • Cannabis Use Disorder
  • tDCS
  • Neuilly sur Marne, France
  • +1 more
Mar 23, 2023

Schizophrenia, Cannabis Use Disorder Trial (Delta-9-THC, Placebo)

Not yet recruiting
  • Schizophrenia
  • Cannabis Use Disorder
  • (no location specified)
Sep 21, 2023

Schizophrenia Trial in Bron (Cannabis and thought disorder in schizophrenia:clinical and neuroimaging relationships)

Recruiting
  • Schizophrenia
  • Cannabis and thought disorder in schizophrenia:clinical and neuroimaging relationships
  • Bron, Auvergne Rhone Alpes, France
    Centre Hospitalier Le Vinatier
Mar 15, 2022

Schizophrenia, Cannabis-Induced Disorder Trial in France (Transcranial direct current stimulation (tDCS) active, Transcranial

Not yet recruiting
  • Schizophrenia
  • Cannabis-Induced Disorder
  • Transcranial direct current stimulation (tDCS) active
  • Transcranial direct current stimulation (tDCS) non active
  • Bron, France
  • +6 more
Nov 29, 2022

Psychotic Disorders, Cannabis Use Disorder, Cannabis Dependence Trial in Montréal (Contingency management)

Recruiting
  • Psychotic Disorders
  • +7 more
  • Contingency management
  • Montréal, Quebec, Canada
    Douglas Mental Health University Institute
Jun 30, 2022

Schizophrenia, Cannabis Use Trial in London (Cannabidiol, Placebo, Delta-9-THC)

Recruiting
  • Schizophrenia
  • Cannabis Use
  • London, United Kingdom
    South London and Maudsley NHS Foundation Trust
Aug 16, 2022

Schizophrenia, Dual Diagnosis, Psychotic Disorder Trial in Lebanon, Burlington (Marijuana, Dronabinol, Placebo)

Completed
  • Schizophrenia
  • +3 more
  • Lebanon, New Hampshire
  • +1 more
Oct 11, 2021

Psychosis, Schizophrenia, At-risk Mental State Trial (Language assessment, TLC - Scale for the Assessment of Thought, Language,

Not yet recruiting
  • Psychosis
  • +3 more
  • Language assessment
  • +3 more
  • (no location specified)
Sep 12, 2023

Schizophrenia, Dual Diagnosis, Schizoaffective Disorder Trial in Lebanon (Dronabinol, Cannabis)

Completed
  • Schizophrenia
  • +4 more
  • Lebanon, New Hampshire
    Dartmouth Hitchcock Medical Center
Jul 8, 2021

Psychosis, Cannabis Use, THC Trial in West Haven (Placebo, Very Low Dose THC, Low Dose THC)

Active, not recruiting
  • Psychosis
  • +4 more
  • Placebo
  • +2 more
  • West Haven, Connecticut
    VA Connecticut Healthcare System
Jul 21, 2022

Psychosis, Substance Use, Substance Use Disorders Trial in Belmont (CRAFT-FT)

Completed
  • Psychosis
  • +14 more
  • CRAFT-FT
  • Belmont, Massachusetts
    McLean Hospital
Sep 16, 2022

Imaging Cannabinoid Receptors Using Positron Emission Tomography

Recruiting
  • Schizophrenia
  • +6 more
  • [11-C]OMAR
  • New Haven, Connecticut
    Connecticut Mental Health Center, Clinical Neuroscience Research
Feb 23, 2022

Schizophrenia Spectrum Disorders, Cannabis Use Trial in Los Angeles, Baltimore, Catonsville (Cannabidiol (CBD), Placebo)

Withdrawn
  • Schizophrenia Spectrum Disorders
  • Cannabis Use
  • Cannabidiol (CBD)
  • Placebo
  • Los Angeles, California
  • +2 more
Apr 14, 2021

Psychosis, Substance Use, Substance Use Disorders Trial in Belmont (CRAFT-EP, TAU)

Recruiting
  • Psychosis
  • +10 more
  • CRAFT-EP
  • TAU
  • Belmont, Massachusetts
    McLean Hospital
Jun 2, 2022

Dual Diagnosis Trial in Glostrup (Cannabidiol, Risperidone)

Recruiting
  • Dual Diagnosis
  • Glostrup, Denmark
    Center for Neuropsychiatric Schizophrenia Research
Jun 7, 2021

Schizophrenia, Schizoaffective Disorder Trial in Pittsburgh (CET/PT, Treatment as Usual)

Completed
  • Schizophrenia
  • Schizoaffective Disorder
  • CET/PT
  • Treatment as Usual
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Apr 10, 2020

Psychotic Disorders, Cannabis Use Disorder, Mental Health Disorder Trial in Montréal (Avatar Intervention)

Active, not recruiting
  • Psychotic Disorders
  • +2 more
  • Avatar Intervention
  • Montréal, Quebec, Canada
    Research center of the Institut universitaire en santé mentale d
Feb 17, 2023

Repetitive Transcranial Magnetic Stimulation (rTMS), Schizophrenia, Cannabis Use Disorder Trial in Toronto (Repetitive

Unknown status
  • Repetitive Transcranial Magnetic Stimulation (rTMS)
  • +3 more
  • Repetitive Transcranial Magnetic Stimulation (rTMS)
  • +2 more
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Nov 12, 2019

Schizophrenia, Schizoaffective Disorder, Substance Use Disorders Trial in Boston, Worcester, Chapel Hill (Brexpiprazole,

Recruiting
  • Schizophrenia
  • +2 more
  • Boston, Massachusetts
  • +2 more
May 31, 2022

Cannabis Use Disorder Trial in Canada (iCanChange)

Not yet recruiting
  • Cannabis Use Disorder
  • iCanChange
  • Calgary, Alberta, Canada
  • +4 more
Mar 31, 2022

Schizophrenia, Mental Disorders, Psychotic Disorders Trial in West Haven (THC and Iomazenil, Placebo (control))

Completed
  • Schizophrenia
  • +2 more
  • THC and Iomazenil
  • Placebo (control)
  • West Haven, Connecticut
    VA Connecticut Healthcare System
Dec 2, 2022

Cannabis Use, MDD, Cognitive Impairment Trial in Toronto (Contingency Reinforcement, Non-Contingency Reinforcement)

Recruiting
  • Cannabis Use
  • +2 more
  • Contingency Reinforcement
  • Non-Contingency Reinforcement
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Mar 7, 2022

COMT Gene Polymorphism Trial in West Haven (delta 9 tetrahydrocannabinol)

Completed
  • COMT Gene Polymorphism
  • delta 9 tetrahydrocannabinol
  • West Haven, Connecticut
    VA Connecticut Healthcare System
Feb 23, 2022

Mental Illness, Schizophrenia, Bipolar Disorder Trial in Halifax (Genetic counselling)

Unknown status
  • Mental Illness
  • +5 more
  • Genetic counselling
  • Halifax, Nova Scotia, Canada
    Nova Scotia Health Authority
Jul 22, 2019